Literature DB >> 6775182

Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate.

A Kober, Y Olsson, I Sjöholm.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775182

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  8 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  Differential kinetics of phenytoin in elderly patients.

Authors:  K A Bachmann; R J Belloto
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

3.  Serum protein binding of tolbutamide in patients treated with antiepileptic drugs.

Authors:  M C Fernández; S Erill; M I Lucena; E Pita; N Pérez-Alférez
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

Review 4.  Protein binding displacement interactions and their clinical importance.

Authors:  J C McElnay; P F D'Arcy
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

5.  Plasma protein binding of phenytoin in 100 epileptic patients.

Authors:  G M Peterson; S McLean; S Aldous; R J Von Witt; K S Millingen
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

6.  Variability of carbamazepine and valproate concentrations in elderly nursing home residents.

Authors:  Angela K Birnbaum; Jeannine M Conway; Melissa A Strege; Ilo E Leppik
Journal:  Epilepsy Res       Date:  2012-03-30       Impact factor: 3.045

Review 7.  Drug interactions with valproic acid.

Authors:  R H Levy; K M Koch
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

8.  The effects of peritoneal dialysis on the single dose and steady state pharmacokinetics of valproic acid in a uremic epileptic child.

Authors:  J M Orr; K Farrell; F S Abbott; S Ferguson; W J Godolphin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.